---
$id: https://graph.org.ai/products/commodity/51161571
$type: Product
source: UNSPSC
code: "51161571"
title: "Nivimedone sodium"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nivimedone sodium

**UNSPSC Code**: 51161571
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a mast cell stabilizer with the molecular formula C11H8NO4.Na.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4953C873N2, chemically known as 1h-indene-1,3(2h)-dione, 5,6-dimethyl-2-nitro-, ion(1-), sodium, monohydrate but more generally known as nivimedone sodium, which bears US NIH Compound Identifier 43916. Most nations, for tariff and trade purposes, schedule nivimedone sodium under HS 29147000 and SITC 51629. As of Q4 2014, NIVIMEDONE SODIUM remains US FDA's Preferred Term for this commodity. Nivimedone sodium bears US NLM identifiers UMLS ID C0132621 and NCI Concept Code C72941. SMILES: CC1CC2C(CC1C)C(=O)C(=[N+]([O-])[O-])C2=O.O.[NA+].

